12:00 AM
 | 
Feb 27, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Sanofi sales and marketing update

Sanofi's Genzyme Corp. unit recalled lot 2020898 of 50 mg intravenous Fludara fludarabine because of a "lack of assurance...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >